Project Grant R41AG085701
Award Date
9/25/24
Completion Date
8/31/25
Dollars Obligated
$449K
Federal Agency
National Institute on Aging
Awardee
Telohealthdx LLC (ZWK6WMUV43G5)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Clarksburg, MD 20871, USA
Similar Awards
This $430,101 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Vanderbilt University Medical Center (VUMC) will fund research to identify new genes and genetic variants responsible for telomere shortening, telomere disease risk, and premature aging. The project aims to determine the genetic basis of telomere shortening across diverse tissues, explore the phenome-wide consequences of telomere length using large-scale biobank data, and identify...
The National Institute on Aging (CFDA 93.866) awarded a $1,274,993 Project Grant to Epicypher, Inc. to develop a new approach called Reverse Transcribe & Tagmentation (RT & TAG) for identifying chromatin-associated RNAs (CARNAs), including nascent RNA transcripts, to accelerate aging and Alzheimer's disease/age-related dementia (AD/ADRD) research. The central innovation is an immunotethering-based method for in situ targeted tagmentation of CARNAs. The project also involves developing...
This federal Project Grant award of $404,792 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate the mechanisms regulating telomere length, protection, and replication. The key objectives of this 5-year project are to: 1) determine how the POT1 protein coordinates telomere length maintenance through a phospho-dephospho switch, 2) explore how the TRF2-RAP1 complex protects...
This $2.77 million project grant from the Department of Health and Human Services' Assistant Secretary for Financial Resources will support research at the University of Wisconsin-Madison to develop new single-molecule tools to characterize the human telomere chromatin landscape. Over three years, the researchers will establish proof-of-concept experiments using non-native DNA methylation to map protein-DNA interactions at repetitive telomeric DNA regions. They will then use these new tools to...
This $1,274,632 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of CUTANA-RH, a novel platform for genome-wide profiling of R-loops to accelerate aging and neurodegenerative disease research. The key products and services to be delivered under this 21-month grant include: Developing a modular immunotethering strategy for genomic mapping of R-loops, which leverages a catalytically inactive RNase H1 enzyme as a highly...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $472,695 project grant to 3D Bioanalytix, Inc. to develop a blood-based diagnostic test for early detection and differentiation of neurodegenerative diseases such as Alzheimer's and Parkinson's. The project leverages the company's Covalent Protein Painting (CPP) platform technology to detect and identify misfolded protein aggregates that characterize these diseases. This novel...
The National Institute on Aging (NIA) awarded a $514,862 Project Grant (CFDA 93.866 - Aging Research) to Neuroindx, a for-profit, woman-owned small business, to develop an on-chip functional assay for identifying candidate microtubule-binding drugs to treat Alzheimer's Disease and related disorders (ADRDs). The goal of the project is to create an in vitro assay that can replicate key features of the neuronal microtubule microenvironment and use kinesin-based readouts to measure the ability of...
This $500,000 Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) will support Sxrna Technologies, Inc. in developing an organoid toolkit for Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD). The company aims to create a platform for identifying senescent cells in living tissue, which can provide insights into the aging process and enable high-throughput drug screening in complex 3D tissue models. Specifically, the grant will fund...
The National Institute on Aging (NIA) awarded a $430,956 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Duke University. The grant aims to (1) identify novel clinical and 'omic risk factors, including telomere length, mitochondrial copy number, and clonal hematopoiesis, for organ dysfunction and early mortality in sickle cell disease (SCD), and (2) identify proteomic and glycoproteomic biomarkers for premature mortality in SCD. The research seeks to elucidate the...
This $1,044,855 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund Nemalife Inc. to deliver high-throughput testing of anti-aging and FDA-approved drugs in genetically diverse invertebrate Alzheimer's disease models. Under the Aging Research program (CFDA 93.866), the awardee will screen 300 anti-aging compounds and 200 FDA drugs to identify candidates that improve neuronal aging and protect against protein misfolding diseases...